The clinical figures that count.
Start enjoying the benefits of College membership today. Take a look at what the College can offer you and view our membership categories and rates.
The Medicine & Healthcare products Regulatory Agency (MHRA) has approved the first licensed low-dose atropine (LDA) treatment for slowing the progression of childhood myopia.
We are concerned that primary eye care has been omitted as a priority opportunity in the framework.
An online webinar on AI and eyecare.